Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022;400:1803–20.

Article  PubMed  Google Scholar 

Hudish LI, Reusch JE, Sussel L. Beta cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019;129:4001–08.

Article  PubMed  PubMed Central  Google Scholar 

Trico D, Mengozzi A, Baldi S, Bizzotto R, Olaniru O, Toczyska K, et al. Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals. Metabolism. 2022;134:155247.

Article  CAS  PubMed  Google Scholar 

Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF. Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab. 2011;300:E255–62.

Article  CAS  PubMed  Google Scholar 

Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50:1505–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langenberg C, Lotta LA. Genomic insights into the causes of type 2 diabetes. Lancet. 2018;391:2463–74.

Article  CAS  PubMed  Google Scholar 

Krentz NAJ, Gloyn AL. Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics. Nat Rev Endocrinol. 2020;16:202–12.

Article  CAS  PubMed  Google Scholar 

Brouwers M, Jacobs C, Bast A, Stehouwer CDA, Schaper NC. Modulation of glucokinase regulatory protein: a double-edged sword? Trends Mol Med. 2015;21:583–94.

Article  CAS  PubMed  Google Scholar 

Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9:2941.

Article  PubMed  PubMed Central  Google Scholar 

Mahajan A, Wessel J, Willems SM, Zhao W, Robertson NR, Chu AY, et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat Genet. 2018;50:559–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donertas HM, Fabian DK, Valenzuela MF, Partridge L, Thornton JM. Common genetic associations between age-related diseases. Nat Aging. 2021;1:400–12.

Article  PubMed  PubMed Central  Google Scholar 

Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, Balkau B, et al. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes. 2008;57:2253–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44:659–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoofnagle AN, Vaisar T, Mitra P, Chait A. HDL lipids and insulin resistance. Curr Diab Rep. 2010;10:78–86.

Article  CAS  PubMed  Google Scholar 

Eto K, Yamashita T, Matsui J, Terauchi Y, Noda M, Kadowaki T. Genetic manipulations of fatty acid metabolism in β-cells are associated with dysregulated insulin secretion. Diabetes. 2002;51:S414–S20.

Article  CAS  PubMed  Google Scholar 

Brehm A, Pfeiler G, Pacini G, Vierhapper H, Roden M. Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin Chem. 2004;50:2316–22.

Article  CAS  PubMed  Google Scholar 

Giannini C, Santoro N, Caprio S, Kim G, Lartaud D, Shaw M, et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care. 2011;34:1869–74.

Article  PubMed  PubMed Central  Google Scholar 

Baldi S, Bonnet F, Laville M, Morgantini C, Monti L, Hojlund K, et al. Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study. Diabetes Care. 2013;36:4125–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rasouli N, Younes N, Utzschneider KM, Inzucchi SE, Balasubramanyam A, Cherrington AL, et al. Association of baseline characteristics with insulin sensitivity and beta-cell function in the glycemia reduction approaches in diabetes: a comparative effectiveness (GRADE) study cohort. Diabetes Care. 2021;44:340–49.

Article  CAS  PubMed  Google Scholar 

Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, et al. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of beta cell function in a Chinese population with different glucose tolerance status. Lipids Health Dis. 2016;15:104.

Article  PubMed  PubMed Central  Google Scholar 

Natali A, Baldi S, Bonnet F, Petrie J, Trifiro S, Trico D, et al. Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects. Metabolism. 2017;69:33–42.

Article  CAS  PubMed  Google Scholar 

Fiorentino TV, Succurro E, Marini MA, Pedace E, Andreozzi F, Perticone M, et al. HDL cholesterol is an independent predictor of beta-cell function decline and incident type 2 diabetes: a longitudinal study. Diabetes Metab Res Rev. 2020;36:e3289.

Article  CAS  PubMed  Google Scholar 

Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, Nakayama T. Impact of serum triglyceride and high density lipoprotein cholesterol levels on early-phase insulin secretion in normoglycemic and prediabetic subjects. Diabetes Metab J. 2014;38:294–301.

Article  PubMed  PubMed Central  Google Scholar 

Dannecker C, Wagner R, Peter A, Hummel J, Vosseler A, Haring HU, et al. Low-density lipoprotein cholesterol is associated with insulin secretion. J Clin Endocrinol Metab. 2021;106:1576–84.

Article  PubMed  PubMed Central  Google Scholar 

Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho-Melander M, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet. 2009;18:4081–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes. 2008;57:3112–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chambers JC, Zhang W, Zabaneh D, Sehmi J, Jain P, McCarthy MI, et al. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes. 2009;58:2703–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Revez JA, Lin T, Qiao Z, Xue A, Holtz Y, Zhu Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11:1647.

Article  PubMed  PubMed Central  Google Scholar 

Manousaki D, Mitchell R, Dudding T, Haworth S, Harroud A, Forgetta V, et al. Genome-wide association study for vitamin D levels reveals 69 independent loci. Am J Hum Genet. 2020;106:327–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Basty N, Whitcher B, Bell JD, Sorokin EP, van Bruggen N, et al. Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning. Elife. 2021;10:e65554.

Stancakova A, Civelek M, Saleem NK, Soininen P, Kangas AJ, Cederberg H, et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes. 2012;61:1895–902.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simons N, Dekker JM, van Greevenbroek MM, Nijpels G, t Hart LM, van der Kallen CJ, et al. A common gene variant in glucokinase regulatory protein interacts with glucose metabolism on diabetic dyslipidemia: the combined CODAM and Hoorn studies. Diabetes Care. 2016;